Skip to search formSkip to main contentSkip to account menu

MEDI4212

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study
IntroductionThe anti-IgE therapy omalizumab is currently licensed for the treatment of moderate to severe allergic asthma and… 
2009
2009
In Vitro Properties of MEDI-4212, a Human Anti-IgE Antibody for the Treatment of Allergic Asthma.
HuFceRI transfected RBL or LAD2 cells were incubated with IgE ± MEDI4212. Bound IgE was cross-linked using a commercial anti-IgE… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)